Doyle Ramona 4
4 · RECURSION PHARMACEUTICALS, INC. · Filed Jan 5, 2022
Insider Transaction Report
Form 4
Doyle Ramona
Chief Medical Officer
Transactions
- Exercise/Conversion
Class A Common Stock
2022-01-03$2.47/sh+40,322$99,595→ 40,322 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-01-03−40,322→ 709,678 totalExercise: $2.47Exp: 2030-12-30→ Class A Common Stock (40,322 underlying)
Footnotes (2)
- [F1]Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person.
- [F2]Twenty-Five percent (25%) of the 750,000 shares originally subject to the award shall vest one year after December 31, 2020, or the Vesting Commencement Date, and one-forty-eighth (148th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Vesting Commencement Date.